Summary We have recently succeeded in producing transgenic mice carrying a hybrid gene consisting of mouse metallothionein promoter-enhancer and the ret oncogene (MT/ret). (Iwamoto et al., 1991b) . A retroperitoneal tumour developed in one of 17 MT/ret transgenic founder mice. Histological analysis revealed that the tumour consisted of undifferentiated neuroblasts and differentiated ganglion cells, the latter of which were strongly postitive for neuron specific enolase. Expression of the ret transgene was observed at high levels in RNA from the tumour, but not in those of other normal tissues. In addition, a 1OOkDa ret protein was detected in the cell lysate of the tumour. Taken together with our previous data, these results suggest a possible role for the ret oncogene in the proliferation of neural crest cells.
The ret proto-oncogene encodes a receptor type tyroine kinase (Takahashi et al., 1988a (Takahashi et al., , 1989 Tahira et al., 1990) and is frequently expressed in human neuroblastoma, pheochromocytoma and thyroid medullary carcinoma that originate from neural crest cells (Takahashi & Cooper, 1987; Ikeda et al., 1990; Santoro et al., 1990; Takahashi et al., 1991) . Although a ligand for the ret proto-oncogene product has not been identified, this finding suggests that the ret proto-oncogene might play a role in the differentiation or proliferation of neural crest cells.
The ret oncogene is a hybrid gene of the ret protooncogene and a 'zinc finger'-containing gene (rfp) (Takahashi et al., 1985; Takahashi & Cooper, 1987; Takahashi et al., 1988b) . This hybrid gene was generated by DNA rearrangement which occurred during the transfection assay. We recently reported the establishment of transgenic mice that carried the ret oncogene driven by a mouse metallothionein regulatory element (Iwamoto et al., 1991b) . We obtained 17 founder mice, four of which unexpectedly showed severe pigmentation in their whole skin, resulting from proliferation of melanin-producing cells. Melanocytic tumours developed in three of the four mice with the pigmented skin. Northern blot and in situ hybridisation experiments indicated that the ret transgene was expressed preferentially in melaninproducing cells. These results indicated that the MT/ret gene affected the proliferation or differentiation of part of the neural crest cells in our transgenic mice. In addition to these mice, we found the development of a retroperitoneal tumour in one MT/ret founder mouse (Iwamoto et al., 1991b) . In the present study, we report the characterisation of this tumour that was histologically diagnosed as a neuroblastoma.
Material and methods

Mice
The methods to produce the MT/ret transgenic mice were described previously (Iwamoto et al., 1991b) . Antibody A polyclonal antibody was developed against the tyrosine kinase domain of the Ret protein (Takahashi et al., 1991 Anti-phosphotyrosine (PTYR) antibody was purified by affinity chromatography from the sera of the rabbits immunised with v-abl-encoded bacterial protein (Hamaguchi et al., 1988) .
Immunohistochemistry
Paraffin sections of neuroblastoma were stained with antineuron specific enolase antibody by a peroxidase antiperoxidase (PAP) method (Wajjwalku et al., 1991) .
Northern hybridisation
Total cellular RNA (15 fig) was isolated by a single step method (Chomczynski & Sacchi, 1987) , separated using agarose formaldehyde gels and transferred to nylon membranes (Amersham, UK). The probe used for this analysis is a PstI-PstI fragment of the kinase domain of the ret oncogene (Iwamoto et al., 1990 (Iwamoto et al., , 1991a . Prehybridisation, hybridisation and washes were performed as described previously (Iwamoto et al., 1990) .
Western blotting Total cell lysates were prepared from tissues of MT/ret transgenic mice (Iwamoto et al., 1991b) as described previously (Takahashi et al., 1991) . The lysates were subjected to SDSpolyacrylamide gel electrophoresis and transferred to nitrocellulose (Schleicher & Schuell, Germany) or polyvinylidene difluoride (PVDF) (Nihon Millipore Kogyo K.K., Yonezawa, Japan) membranes. Reaction with anti-Ret antibody was performed by the avidin-biotin complex immunoperoxidase method. Colour development was performed using the POD immunostain set (Wako Pure Chemical Ind., Ltd., Osaka, Japan). In the case where the anti-PTYR antibody was used as the first antibody, the membranes were probed with '25I-protein A (ICN, Irvine, CA, USA).
Results and discussion
One founder male (designated 301) of the MT/ret transgenic mice developed a tumour on the back at 3 months of age. Since the tumour grew rapidly, the animal was sacrificed at 3. corresponded to nerve fibers (Figure la) . Histochemical analysis indicated that the ganglion cells were strongly positive for neuron specific enolase, while neuroblasts were weakly stained (Figure lc) . On the other hand, neither of these cells were reactive with anti S-100 antibody (data not shown). Thus the tumour was diagnosed as a neuroblastoma or ganglioneuroblastoma.
We analysed the transgene expression in RNAs from several tissues of the transgenic mouse. As shown in Figure  2 , a 4.5kb transcript of the transgene was detected in the tumour, using a 3' ret cDNA probe corresponding to the tyrosine kinase domain (Figure 2) . A 5' ret cDNA probe corresponding to the rfp sequence also detected the same 4.5kb transcript (data not shown), indicating that this transcript was derived from the transgene. In other tissues, its expression was weak or undetectable.
Our recent study (Taniguchi et al., 1992) detected in the lysates from normal liver and kidney of a transgenic mouse with melanocytic tumours. The same 100kDa Ret protein was also observed in the cell lysate of the neuroblastoma, while the presence of a 96kDa Ret protein was unclear (Figure 3) . Rather, the anti-Ret antibody recognised a broad band of 93 to I100kDa in the lysate of the neuroblastoma, suggesting that part of the Ret (Figure 4) . Although several kinds of transgenic mice carrying oncogenes driven by a metallothionein regulatory unit have been produced (Messing et al., 1985; Ruther et al., 1987; Heisterkamp et al., 1990) , there have been no reports of development of neuroblastoma. In addition, there was no spontaneous development of neuroblastoma in the MTlret transgenic mice. It is known that the ret proto-oncogene is expressed at high levels in human neuroblastomas (Takahashi & Cooper, 1987; Ikeda et al., 1990; Nagao et al., 1990; Takahashi et al., 1991) . Thus, it is interesting that neuroblastoma developed in an MTlret transgenic mouse. Since the Ret proteins are present as membrane-bound glycoproteins like the proto-Ret proteins (Taniguchi et al., 1992) , it is possible that both of them have similar functions in prolifera- tion of neuroblasts. The fact that four of 17 MT/ret transgenic founder mice displayed disorders of melanoblasts which also originate from the neural crest cells (Iwamoto et al., 1991b) 
